Zolapse is a powerful sedative created by a European pharmaceutical alliance in 2002. A powerful cure for insomnia, Zolapse can almost instantly put a person to sleep and cause up to a minute of memory loss, making the drug heavily controlled in legal markets.
Zolapse is concentrated into gel capsules for easy digestion. The outer core of a Zolapse pill dissolves immediately, its effects then causing the claustrum of those who ingest it to induce sleep by effectively switching the brain off. The stimulation of the claustrum tends to result in roughly the minute or so prior to the drug kicking in to be lost, and the sleep can easily last up to six hours depending on the dosage. An overdose can be fatal as it can either put the person who ingests the pills into a coma or, worse, starve the brain of oxygen to the point of brain death.
Zolapse was first discovered in Paris in the 1980s, but at the time was considered too dangerous. Early Zolapse was effectively just used to induce medical comas, and even then there were questions of its reliability. It was in the 1990s that the drug was slowly refined, and even then drug administrations were cautious to approve it for what would become a prescription sleeping pill. It was only with the employment of a gel container that Zolapse was finally considered safe for consumers. It was in 2005 that the drug was first reported being used for less reputable activities, thus it remains a major drug to be monitored by the likes of Interpol and Europol.
In 2006 the Cheon Ninja Force discovered that raw Zolapse, rather than diluted so it could be approved for regular consumption, was a viable sleeping drug. Modified, Zolapse became Fukai Nemuri. While still retaining its natural green color Fukai Nemuri can be employed as both a gas and liquid, keeping the guarantee of at least one minute of short term memory loss and also easier to measure in terms of dosage for duration with less chance for an overdose.